1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs
Authors:
Open Access
- 13 October 2021
- journal article
- review article
- Published by Elsevier in Immuno-Oncology and Technology
- Vol. 11, 100042
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation
- National Institutes of Health
- National Cancer Institute (U01CA238720, U54CA210180)
- National Institute of Environmental Health Sciences
- Melanoma Research Alliance (565436)
This publication has 54 references indexed in Scilit:
- A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)OncoImmunology, 2012
- MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomicsNature Methods, 2011
- The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulationMolecular Systems Biology, 2011
- Mass Spectrometry Analysis and Quantitation of Peptides Presented on the MHC II Molecules of Mouse Spleen Dendritic CellsJournal of Proteome Research, 2011
- Comparative Quantitative Mass Spectrometry Analysis of MHC Class II-Associated Peptides Reveals a Role of GILT in Formation of Self-Peptide RepertoirePLOS ONE, 2010
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- SILAC Mouse for Quantitative Proteomics Uncovers Kindlin-3 as an Essential Factor for Red Blood Cell FunctionCell, 2008
- Generation of peptide–MHC class I complexes through UV-mediated ligand exchangeNature Protocols, 2006
- The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer CellsMolecular & Cellular Proteomics, 2006
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992